跳至主要内容
临床试验/NCT00695084
NCT00695084已完成1 期

Constraint-Induced Movement Therapy Trial for Progressive Multiple Sclerosis

National Multiple Sclerosis Society2 个研究点 分布在 1 个国家目标入组 7 人开始时间: 2007年3月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
7
试验地点
2
主要终点
Improvement on the Motor Activity Log

研究概览

简要总结

This trial will evaluate whether progressive multiple sclerosis associated with hemiparesis may benefit from Constraint-Induced Movement Therapy.

详细描述

Constraint-Induced Movement Therapy was developed to treat stroke hemiparesis. Due to the similarity between multiple sclerosis and stroke in terms of chronic motor deficit, this trial will attempt to determine whether multiple sclerosis may benefit similarly from Constraint-Induced Movement Therapy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Chronic upper extremity motor deficit due to multiple sclerosis

排除标准

  • Relapse within 3 months of planned enrollment.

结局指标

主要结局

Improvement on the Motor Activity Log

时间窗: One year

次要结局

  • Improvement on the Wolf Motor Function Test(Pre to post-treatment)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验